Endoscopic surveillance in Barrett's esophagus

Minerva Gastroenterologica e Dietologica

Volumn 48, Issue 2, 2002, Pages 63-71

  Lunedei, V ^a   Bazzoli, F ^a   Pozzato, P ^a   De Luca, L ^a   Zagari, R M ^a   Fossi, S ^a   Ricciardiello, L ^a   Maltoni, S ^a   Roda, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Barrett esophagus; Complications Esophageal neoplasms Adenocarcinoma Esophagoscopy; Diagnosis Barrett esophagus

Indexed keywords

EID: 66149087919     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Blot WJ, Devesa S, Kneller R, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265(10):1287-9.
2. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in incidence of esophaeal and gastric carcinoma in the United States. Cancer 1988;83:2049-53.
3. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440-3.
4. Botterweck AA, Schouten LJ, Volovics A. Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European country. Int J Epidemiol 2000;29:645-54.
5. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295(9):476-80.
6. Schnell TG, Sontag SJ. Adenocarcinoma arising in tongues or short segment of Barrett' esophagus. Dig Dis 1992;37:137-43.
7. Nandurkar S, Talley NJ. Short segment Barrett's esophagus: prevalence, diagnosis and associations. Gut 1997;40:710-5.
8. Kim SL, Waring PJ, Spechler SJ, Sampliner RE, Doos WG, Krol WF et al. Diagnostic inconsistencies in Barrett's esophagus. Gastroenterology 1994;107(4):945-9.
9. Jass JR. Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 1980;33(9):801-10.
10. Richard E. Sampliner. Practice Guidelines on the Diagnosis, Surveillance, and Therapy of Barrett's Esophagus. Am J Gastroenterol 1998;93:1028-32.
11. Beck I, Champion M. The second Canadian Consensus conference on the management of patients with gastroesophagus reflux disease. Can. J. Gastroenterol 1997;11:7B-20.
12. American Society for Gastrointestinal Endoscopy. The role of endoscopy in the surveillance of premalignant condition of the upper gastrointestinal tract. Guidelines for clinical application. Manchester: The Society, 1986.
13. Robertson CS, Mayberry JF. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
14. Rusch VW, Levine DS. The management of high-grade dysplasia and early cancer in Barrett' esophagus. A multidisciplinary problem. Cancer 1994;74:1225-9.
15. Sampliner RE. Ablative therapies for the columnarlined esophagus. Gastroenterol Clin North Am 1997;26:685-94.
16. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE constorium. Gastroenterology Outcomes research Group in Endoscopy. Am J gastroenterol 1997;92(8):1293-7.
17. Spechler SJ. The Columnar-lined Esophagus, Intestinal Metaplasia, and Norman Barett. Gastroenterol 1996;110:614-21.
18. Streitz J, Andrews C. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993;105:383-8.
19. Thomas P, Doddoli C. Changing patterns and surgical results in adenocarcinoma of the esophagus. Br J Surg 1997;84:119-25.
20. Van Sandick J. Impact of endoscopic biopsy surveillance of Barrett's esophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
21. Van Der Burgh A, Dees J. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
22. Spechler S, Robbins A. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984;87:92-933.
23. Cameron A, Ott B. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
24. Bigard MA, Bretagne JF, Colin R. Reflux gastro-oesophagien de l'adulte. Conference de consensus franco-beige. Gastroenterol Clin Biol 1999;23:S1-320.
25. Provenzale D, Kemp JA. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670-80.
26. Spechler SJ. Barrett's esophagus: diagnosis and management. Bailliere's Clinical Gastroenterol 2000;14:857-79.
27. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's esophagus. Gut 1991;32:1441-6.
28. Sampline R, Fennerty M, Garewal H. Barett's esophagus should we worry and if so why? Semin Gastrointest Dis 1992;3:151-5.
29. Iftikhar S, James P, Steele R. Length of Barrett's esophagus: An important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155-8.
30. Haggitt R. Barrett's esophagus, dysplasia and adenocarcinoma. Human Pathol 1994;25:982-3.
31. Geboes K. Barrett's esophagus: the Metaplasia-Dysplasia-Carcinoma sequence: Morphological aspects. Acta Gastro-F.nterol Belg Symposium 2000;63:13-7.
32. Katz D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barret's esophagus. Am J Gastoenterol 1998;93:536-41.
33. Williamson W, Ellis F Jr. Barrett's esophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151:2212-6.
34. Sagan C, Flejou J. Reproducibility of histological criteria of dysplasia in Barrett mucosa. Gastroenterol Clin Biol 1994;18:D31-4.
35. Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Barrett's esophagus. Correlation between flow citometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987;93(1):1-11
36. Schnell T, Sontag G, Chejfac G. High grade dysplasia in Barrett's esophagus: A report of the experience with 43 patients. Gastroenterology 1989;96:1746.
37. Weston AP, Krmpotich PT, Cherian R. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997;92:407-13.
38. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high grade dysplasia from early adenocarcinoma in Barett's esophagus. Gastroenterology 1993;105(1):40-50.
39. Dees J, Van Der Burgh A, Hop WC, Van Blankenstein M. Identification of a substantial risk factor for development of carcinoma in Barett's esophagus. Gastroenterology 1996;110:A507.
40. Ireland AP, Clark GW, De Meester TR. Barrett's esophagus. The significance of p53 in clinical practice. Ann Surg 1997;225(1):17-30.
41. Cameron AJ. Barrett's esophagus and adenocarcinoma: from the familv to the gene. Gastroenterology 1992;102:1421-4.
42. Tytgat G. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy 1995;27:19-26.
43. Robaszkiewicz M. Endobrachyoesophage: situation actuelle du risque et politique de surveillance. Presse Med 1994;23:1846-8.
44. Ferraris R, Bonelli L, Conio M, Fracchia M, Lapertosa G, Aste H. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance program. Eur J Gastroenterol Hepatol 1997;9(9):881-5.
45. Wright T. High-grade dysplasia in Barrett's esophagus. Br J Surg 1997;84:760-6.
46. De Looze D. Endoscopic follow-up of Barrett's esophagus: protocol and implications. Acta Gastroenterol Belg 2000;63:29-35.
47. Falk G, Rice T, Goldblum J. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999;49:170-6.
48. Hameeteman W, Tytgat IN, Houthoff HJ, Van Den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;69(5 Pt):1249-56.
49. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119(2):333-8.
50. Bytzer P, Christensen P, Damkier P, Vinding K, Seersholm N. Adenocarcinoma of the esophagus and Barrett's esophagus: a population based study. Am J Gastroenterol 1999;94(1):86-91.
51. Altorki N, Oliveria S, Schrump D. Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin Surg Oncol 1997;13:270-80.
52. Streitz J, Ellis F, Tilden R, Erickson RV. Endoscopic surveillance of Barrett's esophagus: A cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 1998;93(6):911-5.